KCNE2
Overview[edit | edit source]
KCNE2 is a gene that encodes a protein known as MinK-related peptide 1 (MiRP1), which is a member of the KCNE family of voltage-gated potassium (K+) channel ancillary subunits. These subunits are crucial for the modulation of cardiac and other physiological processes by altering the properties of potassium channels.
Structure[edit | edit source]
The KCNE2 gene is located on chromosome 21 in humans. The protein product, MiRP1, is a small transmembrane protein that interacts with various potassium channel alpha subunits to modify their function. MiRP1 is characterized by a single transmembrane domain, an extracellular N-terminus, and a cytoplasmic C-terminus.
Function[edit | edit source]
MiRP1 modulates the function of several potassium channels, including the HERG (human ether-à-go-go-related gene) channel, which is critical for cardiac repolarization. By associating with HERG, MiRP1 alters the kinetics and voltage dependence of the channel, impacting the cardiac action potential duration and, consequently, heart rhythm.
File:Differential-Association-between-HERG-and-KCNE1-or-KCNE2-pone.0000933.s002.ogv
Clinical Significance[edit | edit source]
Mutations in the KCNE2 gene have been associated with various cardiac arrhythmias, including Long QT syndrome and ventricular fibrillation. These conditions can lead to syncope, seizures, or sudden cardiac death. The role of KCNE2 in these pathologies underscores the importance of proper potassium channel function in maintaining cardiac electrical stability.
Interactions[edit | edit source]
KCNE2 interacts with several potassium channel alpha subunits, including HERG, KCNQ1, and others. These interactions are essential for the proper functioning of the channels, influencing their gating properties and response to physiological stimuli.
Research[edit | edit source]
Ongoing research is focused on understanding the precise mechanisms by which KCNE2 modulates potassium channel function and its role in cardiac and other physiological processes. Studies also aim to elucidate the impact of specific KCNE2 mutations on channel function and disease.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
